Search

Your search keyword '"Lim, M.J."' showing total 39 results
Start Over Author "Lim, M.J."
39 results on '"Lim, M.J."'

3. Improved Light Conversion Efficiency Of Dye-Sensitized Solar Cell By Dispersing Submicron-Sized Granules Into The Nano-Sized TiO2 Layer

Author

Song S.A., Lim M.J., Jung K.Y., So W.-W., and Moon S.-J.

Subjects
Titania nanoparticles, Granules, Dye-sensitized solar cell, Light scattering, Spray pyrolysis, Mining engineering. Metallurgy, TN1-997, Materials of engineering and construction. Mechanics of materials, TA401-492
Abstract

In this work, TiO2 nanoparticles and submicron-sized granules were synthesized by a hydrothermal method and spray pyrolysis, respectively. Submicron-sized granules were dispersed into the nano-sized TiO2 layer to improve the light conversion efficiency. Granules showed better light scattering, but lower in terms of the dye-loading quantity and recombination resistance compared with nanoparticles. Consequently, the nano-sized TiO2 layer had higher cell efficiency than the granulized TiO2 layer. When dispersed granules into the nanoparticle layer, the light scattering was enhanced without the loss of dye-loading quantities. The dispersion of granulized TiO2 led to increase the cell efficiency up to 6.51%, which was about 5.2 % higher than that of the electrode consisting of only TiO2 nanoparticles. Finally, the optimal hydrothermal temperature and dispersing quantity of granules were found to be 200°C and 20 wt%, respectively.

Published
2015
Full Text
View/download PDF

4. Arteriopathy Diagnosis in Childhood Arterial Ischemic Stroke: Results of the Vascular Effects of Infection in Pediatric Stroke Study

Author

Wintermark, Max, Hills, Nancy K., deVeber, Gabrielle A., Barkovich, A. James, Elkind, Mitchell S.V., Sear, Katherine, Zhu, Guangming, Leiva-Salinas, Carlos, Hou, Qinghua, Dowling, Michael M., Bernard, Timothy J., Friedman, Neil R., Ichord, Rebecca N., Fullerton, Heather J., Benedict, S.L., Fox, C.K., Lo, W.D., Tan, M.A., Mackay, M.T., Kirton, A., Hernandez Chavez, M.I., Humphreys, P., Jordan, L.C., Sultan, S.M., Rivkin, M.J., Rafay, M.F., Titomanlio, L., Kovacevic, G.S., Yager, J.Y., Amlie-Lefond, C., Dlamini, N., Condie, J., Yeh, A., Kneen, R., Bjornson, B.H., Pergami, P., Zou, L.P., Elbers, J., Abdalla, A., Chan, A.K., Farooq, O., Lim, M.J., Carpenter, J.L., Pavlakis, S., Wong, V.C., and Forsyth, R.

Published
2014
Full Text
View/download PDF

5. MA13.08 Genomic and Transcriptomic Features of Distinct Resistance Trajectories in EGFR Mutant Non-Small Cell Lung Cancer (NSCLC)

Author

Tan, A., primary, Chua, K.P., additional, Teng, Y., additional, Takano, A., additional, Alvarez, J., additional, Nahar, R., additional, Rohatgi, N., additional, Lai, G., additional, Aung, Z., additional, Yeong, J., additional, Lim, K.H.T., additional, Naeini, M., additional, Kassam, I., additional, Jain, A., additional, Tan, W., additional, Gogna, A., additional, Too, C.W., additional, Kanesvaran, R., additional, Ng, Q.S., additional, Ang, M., additional, Rajasekaran, T., additional, Devanand, A., additional, Phua, G.C., additional, Tan, B.S., additional, Lee, Y.Y., additional, Wang, L., additional, Teo, A., additional, Khng, A., additional, Lim, M.J., additional, Suteja, L., additional, Toh, C.K., additional, Lim, W., additional, Iyer, N.G., additional, Tam, W.L., additional, Tan, E., additional, Zhai, W., additional, Hillmer, A., additional, Skanderup, A., additional, and Tan, D., additional

Published
2021
Full Text
View/download PDF

6. P69.05 Molecular and Cellular Heterogeneity Underpin Treatment Response Across a Spectrum of EGFR-Mutant Non-Small Cell Lung Cancer

Author

Yuan, J., primary, Lim, E., additional, Ma, S.M., additional, Chua, K.P., additional, Lee, Y.F., additional, Lim, M.J., additional, Yeo, X.H., additional, Phua, C., additional, Takano, A., additional, Aung, Z., additional, Lim, K.H.T., additional, Tan, E., additional, Tan, D., additional, Chew, G.L., additional, and Tam, W.L., additional

Published
2021
Full Text
View/download PDF

8. Automated Identification of Landmarks During Preprocedure Lumbar Ultrasound for Spinal Anesthesia in Obese Parturients: A Prospective Cohort Study

Author

Tan, H.S., Chan, J.J.I., Oh, T.T., Lim, M.J., Tan, C.W., Sultana, R., and Sng, B.L.

Abstract

(Eur J Anaesthesiol. 2023;40(9):710–714)Traditional neuraxial procedures, relying on palpation, face a notable 27% failure rate. The integration of preprocedure ultrasonography offers a potential solution, although challenges arise in obese parturients, resulting in a 76% procedural success rate compared to over 90% in nonobese counterparts.

Published
2024
Full Text
View/download PDF

9. P2.13-21 MET Addiction Can be Circumvented Through EGFR Inhibition Via AXL in MET-Amplified Primary Resistant EGFR-Mutant NSCLCX.

Author

Kwang, L., primary, Lau, D., additional, Liew, A., additional, Ju, Y., additional, Lim, E., additional, Lai, G., additional, Nahar, R., additional, Teng, Y., additional, Chua, K.P., additional, Alvarez, J., additional, Lim, M.J., additional, Leong, H.S., additional, Chong, F.T., additional, Toh, D., additional, Quah, H.S., additional, Suteja, L., additional, Wang, L.Y., additional, Lim, K.H., additional, Lim, W., additional, Tan, E., additional, Zhai, W.W., additional, Tam, W.L., additional, Iyer, N.G., additional, and Tan, D., additional

Published
2018
Full Text
View/download PDF

14. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.

Author

Leen, W.G., Klepper, J., Verbeek, M.M., Leferink, M., Hofste, T., Engelen, B.G.M. van, Wevers, R.A., Arthur, T., Bahi-Buisson, N., Ballhausen, D., Bekhof, J., Bogaert, P. van, Carrilho, I., Chabrol, B., Champion, M.P., Coldwell, J., Clayton, P., Donner, E., Evangeliou, A., Ebinger, F., Farrell, K., Forsyth, R.J., Goede, C.G. de, Gross, S., Grunewald, S., Holthausen, H., Jayawant, S., Lachlan, K., Laugel, V., Leppig, K., Lim, M.J., Mancini, G., Marina, A.D., Martorell, L., McMenamin, J., Meuwissen, M.E., Mundy, H., Nilsson, N.O., Panzer, A., Poll-The, B.T., Rauscher, C., Rouselle, C.M., Sandvig, I., Scheffner, T., Sheridan, E., Simpson, N., Sykora, P., Tomlinson, R., Trounce, J., Webb, D., Weschke, B., Scheffer, H., Willemsen, M.A.A.P., Leen, W.G., Klepper, J., Verbeek, M.M., Leferink, M., Hofste, T., Engelen, B.G.M. van, Wevers, R.A., Arthur, T., Bahi-Buisson, N., Ballhausen, D., Bekhof, J., Bogaert, P. van, Carrilho, I., Chabrol, B., Champion, M.P., Coldwell, J., Clayton, P., Donner, E., Evangeliou, A., Ebinger, F., Farrell, K., Forsyth, R.J., Goede, C.G. de, Gross, S., Grunewald, S., Holthausen, H., Jayawant, S., Lachlan, K., Laugel, V., Leppig, K., Lim, M.J., Mancini, G., Marina, A.D., Martorell, L., McMenamin, J., Meuwissen, M.E., Mundy, H., Nilsson, N.O., Panzer, A., Poll-The, B.T., Rauscher, C., Rouselle, C.M., Sandvig, I., Scheffner, T., Sheridan, E., Simpson, N., Sykora, P., Tomlinson, R., Trounce, J., Webb, D., Weschke, B., Scheffer, H., and Willemsen, M.A.A.P.

Abstract

1 maart 2010, Contains fulltext : 88466.pdf (publisher's version ) (Closed access), Glucose transporter-1 deficiency syndrome is caused by mutations in the SLC2A1 gene in the majority of patients and results in impaired glucose transport into the brain. From 2004-2008, 132 requests for mutational analysis of the SLC2A1 gene were studied by automated Sanger sequencing and multiplex ligation-dependent probe amplification. Mutations in the SLC2A1 gene were detected in 54 patients (41%) and subsequently in three clinically affected family members. In these 57 patients we identified 49 different mutations, including six multiple exon deletions, six known mutations and 37 novel mutations (13 missense, five nonsense, 13 frame shift, four splice site and two translation initiation mutations). Clinical data were retrospectively collected from referring physicians by means of a questionnaire. Three different phenotypes were recognized: (i) the classical phenotype (84%), subdivided into early-onset (<2 years) (65%) and late-onset (18%); (ii) a non-classical phenotype, with mental retardation and movement disorder, without epilepsy (15%); and (iii) one adult case of glucose transporter-1 deficiency syndrome with minimal symptoms. Recognizing glucose transporter-1 deficiency syndrome is important, since a ketogenic diet was effective in most of the patients with epilepsy (86%) and also reduced movement disorders in 48% of the patients with a classical phenotype and 71% of the patients with a non-classical phenotype. The average delay in diagnosing classical glucose transporter-1 deficiency syndrome was 6.6 years (range 1 month-16 years). Cerebrospinal fluid glucose was below 2.5 mmol/l (range 0.9-2.4 mmol/l) in all patients and cerebrospinal fluid : blood glucose ratio was below 0.50 in all but one patient (range 0.19-0.52). Cerebrospinal fluid lactate was low to normal in all patients. Our relatively large series of 57 patients with glucose transporter-1 deficiency syndrome allowed us to identify correlations between genotype, phenotype and biochemical data. T

Published
2010

15. Glucose transporter-1 deficiency syndrome: The expanding clinical and genetic spectrum of a treatable disorder

Author

Leen, W.G. (Wilhelmina), Klepper, J. (Joerg), Verbeek, M.M. (Marcel), Leferink, M. (Maike), Hofste, T. (Tom), Engelen, B.G.M. (Baziel) van, Wevers, R.A. (Ron), Arthur, T. (Todd), Bahi-Buisson, N. (Nadia), Ballhausen, D. (Diana), Bekhof, J. (Jolita), Bogaert, P. (Patrick) van, Carrilho, I. (Inês), Chabrol, B. (Brigitte), Champion, M.P. (Michael), Coldwell, J. (James), Clayton, P. (Peter), Donner, E. (Elizabeth), Evangeliou, A. (Athanasios), Ebinger, F. (Friedrich), Farrell, K. (Kevin), Forsyth, R.J. (Rob), Goede, C.G.E.L. (Christian) de, Gross, S. (Stephanie), Grünewald, S. (Sonja), Holthausen, H. (Hans), Jayawant, S. (Sandeep), Lachlan, K. (Katherine), Laugel, V. (Vincent), Leppig, K. (Kathy), Lim, M.J. (Ming), Mancini, G.M.S. (Grazia), Marina, A.D., Martorell, L. (Loreto), McMenamin, J. (Joe), Meuwissen, M.E.C. (Marije), Mundy, H. (Helen), Nilsson, N.O. (Nils), Panzer, A. (Axel), Poll-The, B.T., Rauscher, C. (Christian), Rouselle, C.M.R. (Christophe), Sandvig, I. (Inger), Scheffner, T. (Thomas), Sheridan, E. (Eamonn), Simpson, N. (Neil), Sykora, P. (Parol), Tomlinson, R. (Richard), Trounce, J. (John), Webb, D.W.M. (David), Weschke, B. (Bernhard), Scheffer, H. (Hans), Willemsen, M.A. (Michél), Leen, W.G. (Wilhelmina), Klepper, J. (Joerg), Verbeek, M.M. (Marcel), Leferink, M. (Maike), Hofste, T. (Tom), Engelen, B.G.M. (Baziel) van, Wevers, R.A. (Ron), Arthur, T. (Todd), Bahi-Buisson, N. (Nadia), Ballhausen, D. (Diana), Bekhof, J. (Jolita), Bogaert, P. (Patrick) van, Carrilho, I. (Inês), Chabrol, B. (Brigitte), Champion, M.P. (Michael), Coldwell, J. (James), Clayton, P. (Peter), Donner, E. (Elizabeth), Evangeliou, A. (Athanasios), Ebinger, F. (Friedrich), Farrell, K. (Kevin), Forsyth, R.J. (Rob), Goede, C.G.E.L. (Christian) de, Gross, S. (Stephanie), Grünewald, S. (Sonja), Holthausen, H. (Hans), Jayawant, S. (Sandeep), Lachlan, K. (Katherine), Laugel, V. (Vincent), Leppig, K. (Kathy), Lim, M.J. (Ming), Mancini, G.M.S. (Grazia), Marina, A.D., Martorell, L. (Loreto), McMenamin, J. (Joe), Meuwissen, M.E.C. (Marije), Mundy, H. (Helen), Nilsson, N.O. (Nils), Panzer, A. (Axel), Poll-The, B.T., Rauscher, C. (Christian), Rouselle, C.M.R. (Christophe), Sandvig, I. (Inger), Scheffner, T. (Thomas), Sheridan, E. (Eamonn), Simpson, N. (Neil), Sykora, P. (Parol), Tomlinson, R. (Richard), Trounce, J. (John), Webb, D.W.M. (David), Weschke, B. (Bernhard), Scheffer, H. (Hans), and Willemsen, M.A. (Michél)

Abstract

Glucose transporter-1 deficiency syndrome is caused by mutations in the SLC2A1 gene in the majority of patients and results in impaired glucose transport into the brain. From 2004-2008, 132 requests for mutational analysis of the SLC2A1 gene were studied by automated Sanger sequencing and multiplex ligation-dependent probe amplification. Mutation

Published
2010
Full Text
View/download PDF

16. AB0562 A double-blind, placebo-controlled, multicenter trial of tocilizumab in moderate to severe active RA patients with inadequate response to methotrexate in korean population

Author

Lim, M.J., primary, Park, S.H., additional, Shim, S.-C., additional, Baek, H.J., additional, Yoo, D.-H., additional, Kim, H.A., additional, Lee, S.K., additional, Lee, Y.J., additional, Park, Y.E., additional, Cha, H.-S., additional, Park, W., additional, and Song, Y.-W., additional

Published
2013
Full Text
View/download PDF

17. Clinical and molecular phenotype of Aicardi-Goutieres syndrome.

Author

Rice, G., Patrick, T., Parmar, R, Taylor, C.F., Aeby, A., Aicardi, J., Artuch, R., Montalto, S.A., Bacino, C.A., Borroso, B., Baxter, P., Benko, W.S., Bergmann, C., Bertini, E., Biancheri, R., Blair, E., Blau, N., Bonthron, D.T., Briggs, T., Brueton, L., Brunner, H.G., Burke, C.J., Carr, I., Carvalho, D.R., Chandler, K.E., Christen, H.J., Corry, P.C., Cowan, F.M., Cox, H., D'Arrigo, S., Dean, J., Laet, C.E. de, Praeter, C.M. de, Dery, C., Ferrie, C.D., Flintoff, K., Frints, S.G., Garcia-Cazorla, A., Gener, B., Goizet, C., Goutieres, F., Green, A.J., Guet, A., Hamel, B.C.J., Hayward, B.E., Heiberg, A., Hennekam, R.C.M., Husson, M., Jackson, A.P., Jayatunga, R., Jiang, Y.H., Kant, S., Kao, A., King, M., Kingston, H., Klepper, J., Knaap, M.S. van der, Kornberg, A.J., Kotzot, D., Kratzer, W., Lacombe, D., Lagae, L., Landrieu, P.G., Lanzi, G., Leitch, A., Lim, M.J., Livingston, J.H., Lourenco, C.M., Lyall, E.G.H., Lynch, S.A., Lyons, M.J., Marom, D., McClure, J.P., McWilliam, R., Melancon, S.B., Mewasingh, L.D., Moutard, M.L., Nischal, K.K., Ostergaard, J.R., Prendiville, J., Rasmussen, M., Rogers, R.C., Roland, D., Rosser, E.M., Rostasy, K., Roubertie, A., Sanchis, A, Schiffmann, R., Scholl-Burgi, S., Seal, S., Shalev, S.A., Corcoles, C.S., Sinha, G.P., Soler, D., Spiegel, R., Stephenson, J.B., Tacke, U., Tan, T.Y., Willemsen, M.A.A.P., Rice, G., Patrick, T., Parmar, R, Taylor, C.F., Aeby, A., Aicardi, J., Artuch, R., Montalto, S.A., Bacino, C.A., Borroso, B., Baxter, P., Benko, W.S., Bergmann, C., Bertini, E., Biancheri, R., Blair, E., Blau, N., Bonthron, D.T., Briggs, T., Brueton, L., Brunner, H.G., Burke, C.J., Carr, I., Carvalho, D.R., Chandler, K.E., Christen, H.J., Corry, P.C., Cowan, F.M., Cox, H., D'Arrigo, S., Dean, J., Laet, C.E. de, Praeter, C.M. de, Dery, C., Ferrie, C.D., Flintoff, K., Frints, S.G., Garcia-Cazorla, A., Gener, B., Goizet, C., Goutieres, F., Green, A.J., Guet, A., Hamel, B.C.J., Hayward, B.E., Heiberg, A., Hennekam, R.C.M., Husson, M., Jackson, A.P., Jayatunga, R., Jiang, Y.H., Kant, S., Kao, A., King, M., Kingston, H., Klepper, J., Knaap, M.S. van der, Kornberg, A.J., Kotzot, D., Kratzer, W., Lacombe, D., Lagae, L., Landrieu, P.G., Lanzi, G., Leitch, A., Lim, M.J., Livingston, J.H., Lourenco, C.M., Lyall, E.G.H., Lynch, S.A., Lyons, M.J., Marom, D., McClure, J.P., McWilliam, R., Melancon, S.B., Mewasingh, L.D., Moutard, M.L., Nischal, K.K., Ostergaard, J.R., Prendiville, J., Rasmussen, M., Rogers, R.C., Roland, D., Rosser, E.M., Rostasy, K., Roubertie, A., Sanchis, A, Schiffmann, R., Scholl-Burgi, S., Seal, S., Shalev, S.A., Corcoles, C.S., Sinha, G.P., Soler, D., Spiegel, R., Stephenson, J.B., Tacke, U., Tan, T.Y., and Willemsen, M.A.A.P.

Abstract

Contains fulltext : 52556.pdf (publisher's version ) (Closed access)

Published
2007

20. P307 The role of neuroinflammation in Batten disease

Author

Lim, M.J., primary, Seehafer, S.S., additional, Ahmadi, S., additional, Horack, M., additional, Wong, A.M.S., additional, Castaneda, J.A., additional, Benedict, J.W., additional, Weimer, J.M., additional, Curran, T.M., additional, Lin, J.P., additional, Pearce, D.A., additional, and Cooper, J.D., additional

Published
2009
Full Text
View/download PDF

22. Improved Light Conversion Efficiency Of Dye-Sensitized Solar Cell By Dispersing Submicron-Sized Granules Into The Nano-Sized TiO2 Layer.

Author

Song, S.A., Lim, M.J., Jung, K.Y., So, W.-W., and Moon, S.-J.

Subjects
DYE-sensitized solar cells, LIGHT scattering, NANOPARTICLES, DISPERSION (Chemistry), CHEMICAL synthesis, PYROLYSIS
Abstract

In this work, TiO2 nanoparticles and submicron-sized granules were synthesized by a hydrothermal method and spray pyrolysis, respectively. Submicron-sized granules were dispersed into the nano-sized TiO2 layer to improve the light conversion efficiency. Granules showed better light scattering, but lower in terms of the dye-loading quantity and recombination resistance compared with nanoparticles. Consequently, the nano-sized TiO2 layer had higher cell efficiency than the granulized TiO2 layer. When dispersed granules into the nanoparticle layer, the light scattering was enhanced without the loss of dye-loading quantities. The dispersion of granulized TiO2 led to increase the cell efficiency up to 6.51%, which was about 5.2 % higher than that of the electrode consisting of only TiO2 nanoparticles. Finally, the optimal hydrothermal temperature and dispersing quantity of granules were found to be 200°C and 20 wt%, respectively. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

31. A trimodal resonator for three mutually perpendicular magnetic fields.

Author

Stievater, T.H., Lim, M.J., Colosimo, P., Michniak, R.A., Bucksbaum, P.H., and Conti, R.S.

Subjects
*RESONATORS, *MAGNETIC fields
Abstract

Describes a trimodal resonator for the simultaneous delivery of three perpendicular magnetic fields. Shielded loop single-mode radio frequency resonator placed inside a bimodal waveguide microwave resonator; Control of the relative phase between the three fields; Resonator's use to drive magnetic dipole transitions coherently between Zeeman states.

Published
1999
Full Text
View/download PDF

39. PML nuclear body component Sp140 is a novel autoantigen in primary biliary cirrhosis

Author

Daniel Bloch, Luigi Muratori, S. Ferri, Chiara Quarneti, Ayako Nakajima, Alessandro Granito, Francesco B. Bianchi, Wei-Hong Yang, Paolo Muratori, Mark J. Lim, Georgios Pappas, Granito A., Yang W.H., Muratori L., Lim M.J., Nakajima A., Ferri S., Pappas G., Quarneti C., Bianchi F.B., Bloch D.B., and Muratori P.

Subjects
musculoskeletal diseases, Adult, Male, Pathology, medicine.medical_specialty, Anti-nuclear antibody, Adolescent, Cholangitis, Sclerosing, Immunoblotting, Nuclear dots, Autoantigens, Statistics, Nonparametric, Promyelocytic leukemia protein, Primary biliary cirrhosis, Antigen, medicine, Humans, Lupus Erythematosus, Systemic, skin and connective tissue diseases, Fluorescent Antibody Technique, Indirect, Aged, Hepatitis, Lupus erythematosus, Chi-Square Distribution, Hepatology, biology, business.industry, Liver Cirrhosis, Biliary, Gastroenterology, Antigens, Nuclear, Middle Aged, medicine.disease, digestive system diseases, stomatognathic diseases, Hepatitis, Autoimmune, Italy, Antibodies, Antinuclear, Case-Control Studies, biology.protein, Female, Antibody, business, Transcription Factors
Abstract

Some patients with primary biliary cirrhosis (PBC) have antinuclear antibodies (ANAs). These ANAs include the “ multiple nuclear dots ” (MND) staining pattern, targeting promyelocytic leukemia protein (PML) nuclear body (NB) components, such as “ speckled 100-kD ” protein (Sp100) and PML. A new PML NB protein, designated as Sp140, was identifi ed using serum from a PBC patient. The aim of this study was to analyze the immune response against Sp140 protein in PBC patients. METHODS: We studied 135 PBC patients and 157 pathological controls with type 1 autoimmune hepatitis, primary sclerosing cholangitis, and systemic lupus erythematosus. We used indirect immunofl uorescence and a neuroblastoma cell line expressing Sp140 for detecting anti-Sp140 antibodies, and a commercially available immunoblot for detecting anti-Sp100 and anti-PML antibodies. RESULTS: Anti-Sp140 antibodies were present in 20 (15 % ) PBC patients but not in control samples, with a higher frequency in antimitochondrial antibody (AMA)-negative cases (53 vs. 9 % , P < 0.0001). Anti-Sp140 antibodies were found together with anti-Sp100 antibodies in all but one case (19 of 20, 90 % ) and with anti-PML antibodies in 12 (60 % ) cases. Anti-Sp140 positivity was not associated with a specifi c clinical feature of PBC. CONCLUSIONS: Our study identifi es Sp140 as a new, highly specifi c autoantigen in PBC for the fi rst time. The very frequent coexistence of anti-Sp140, anti-Sp100 and anti-PML antibodies suggests that the NB is a multiantigenic complex in PBC and enhances the diagnostic signifi cance of these reactivities, which are particularly useful in AMA-negative cases.

Published
2009

Catalog

Books, media, physical & digital resources
See catalog results